PKC-dependent extracellular signal-regulated kinase 1/2 pathway is involved in the inhibition of Ib on AngiotensinII-induced proliferation of vascular smooth muscle cells

Biochemical and Biophysical Research Communications

Volumn 375, Issue 1, 2008, Pages 151-155

  Wang, Yu ^a   Yan, Tianhua ^a   Wang, Qiujuan ^a   Wang, Wei ^a   Xu, Jinyi ^a   Wu, Xiaoming ^a   Ji, Hui ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

AngiotensinII; AT1 receptor antagonist; Extracellular signal regulated kinases 1 2; Ib; Proliferation; Protein kinase C

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 1 RECEPTOR ANTAGONIST IB; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE C; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; DRUG EFFECT; DRUG INHIBITION; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; IC 50; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHOSPHORYLATION; PROTEIN KINASE C; RABBITS; TETRAZOLES; TRIAZOLES;

EID: 50949088733     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.07.137     Document Type: Article

References (29)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362 (1993) 801-809
2. Dzau V.J. Theodore Cooper Lecture: tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension 37 (2001) 1047-1052
3. Touyz R.M., and Schiffrin E.L. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol. Rev. 52 (2000) 639-672
4. Sugden P.H., and Clerk A. Regulation of the ERK subgroup of MAP kinase cascades through G protein-coupled receptors. Cell Signal. 9 (1997) 337-351
5. Taniyama Y., Ushio-Fukai M., Hitomi H., Rocic P., Kingsley M.J., Pfahnl C., Weber D.S., Alexander R.W., and Griendling K.K. Role of p38 MAPK and MAPKAPK-2 in angiotensin II-induced Akt activation in vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 287 (2004) C494-C499
6. Cohen P. The search for physiological substrates of MAP and SAP kinases in mammalian cells. Trends Cell Biol. 7 (1997) 353-361
7. Viedt C., Soto U., Krieger-Brauer H.I., Fei J., Elsing C., Kubler W., and Kreuzer J. Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 940-948
8. Schonwasser D.C., Marais R.M., Marshall C.J., and Parker P.J. Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes. Mol. Cell. Biol. 18 (1998) 790-798
9. Xu J.Y., Zhou Y.X., and Wu X.M. Synthesis and bioactivity of 1-aryl-3-alkyl-1,4-dihydro-4-substitued-5H-1,2,4,-triazolinones-5. J. China Pharm. Univ. 30 (1999) 323-327
10. Wu J.H., Wang Q.J., Hu S., Xu J.Y., and Wu X.M. Antihypertensive effects of a new angiotensin type 1 receptor antagonist 1b on rats. J. China Pharm. Univ. 36 (2005) 563-566
11. Zhang J., Wang Q.J., Xu J.Y., and Wu X.M. Effects of a new angiotensin type 1 receptor antagonist 1b on the cardiac hypertrophy induced by l-thyroxin in rat. J. China Pharm. Univ. 37 (2006) 157-160
12. 2+]i and PKC-alpha are involved in the inhibitory effects of Ib, a novel nonpeptide AngiotensinII subtype AT1 receptor antagonist, on AngiotensinII-induced vascular contraction in vitro. Biochem. Biophys. Res. Commun. 364 (2007) 118-123
13. Yan B., Wang G., Sun J., Li X., Zheng Y., Ai H., Lv H., Wu X., and Xu J. Identification of the major metabolites of 5-n-butyl-4-{4-[2-(1H-tetrazole-5-yl)-1H-pyrrol-1-yl]phenylmethyl}-2,4-dihSSydro-2-(2,6-dichloridephenyl)-3H-1,2,4-triazol-3-one, a new angiotensin type 1 receptor antagonist, in rat bile by HPLC-diode array detection-MS and HPLC-MS/MS. Biomed. Chromatogr. 21 (2007) 912
14. 2+ entry during coronary artery contraction by vasoactive eicosanoids. Can. J. Physiol. Pharmacol. 76 (1998) 1110-1119
15. Ross R. Cell biology of atherosclerosis. Annu. Rev. Physiol. 57 (1995) 791-804
16. Eguchi S., and Inagami T. Signal transduction of angiotensin II type 1 receptor through receptor tyrosine kinase. Regul. Pept. 91 (2000) 13-20
17. Itoh H., Mukoyama M., Pratt R.E., Gibbons G.H., and Dzau V.J. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J. Clin. Invest. 91 (1993) 2268-2274
18. Hug H., and Sarre T.F. Protein kinase C isoenzymes: divergence in signal transduction?. Biochem. J. 291 Pt. 2 (1993) 329-343
19. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258 (1992) 607-614
20. 2+ ]i threshold for translocation of the alpha-protein kinase C isoform. Am. J. Physiol. 266 (1994) C1544-C1551
21. Liou Y.M., and Morgan K.G. Redistribution of protein kinase C isoforms in association with vascular hypertrophy of rat aorta. Am. J. Physiol. 267 (1994) C980-C989
22. Horowitz A., Menice C.B., Laporte R., and Morgan K.G. Mechanisms of smooth muscle contraction. Physiol. Rev. 76 (1996) 967-1003
23. Kanashiro C.A., and Khalil R.A. Signal transduction by protein kinase C in mammalian cells. Clin. Exp. Pharmacol. Physiol. 25 (1998) 974-985
24. Zou Y., Komuro I., Yamazaki T., Kudoh S., Aikawa R., Zhu W., Shiojima I., Hiroi Y., Tobe K., Kadowaki T., and Yazaki Y. Cell type-specific angiotensin II-evoked signal transduction pathways: critical roles of Gbetagamma subunit, Src family, and Ras in cardiac fibroblasts. Circ. Res. 82 (1998) 337-345
25. Yoshizumi M., Tsuchiya K., Suzaki Y., Kirima K., Kyaw M., Moon J.H., Terao J., and Tamaki T. Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway. Biochem. Biophys. Res. Commun. 293 (2002) 1458-1465
26. Turner N.A., Ball S.G., and Balmforth A.J. The mechanism of angiotensin II-induced extracellular signal-regulated kinase-1/2 activation is independent of angiotensin AT(1A) receptor internalisation. Cell Signal. 13 (2001) 269-277
27. Muscella A., Greco S., Elia M.G., Storelli C., and Marsigliante S. PKC-zeta is required for angiotensin II-induced activation of ERK and synthesis of C-FOS in MCF-7 cells. J. Cell. Physiol. 197 (2003) 61-68
28. Pang L., Nie M., Corbett L., Donnelly R., Gray S., and Knox A.J. Protein kinase C-epsilon mediates bradykinin-induced cyclooxygenase-2 expression in human airway smooth muscle cells. FASEB J. 16 (2002) 1435-1437
29. Fukumoto S., Nishizawa Y., Hosoi M., Koyama H., Yamakawa K., Ohno S., and Morii H. Protein kinase C delta inhibits the proliferation of vascular smooth muscle cells by suppressing G1 cyclin expression. J. Biol. Chem. 272 (1997) 13816-13822